SSY GROUP (02005): Acetylaminophenol tablets approved by the National Medical Products Administration for new 0.5g specification.
Sinopharm Group (02005) announced that the group's paracetamol tablets have been approved by the China National Medical Products Administration...
SSY GROUP (02005) announced that the group's paracetamol tablets have been approved by the National Medical Products Administration of China (NMPA) for a new 0.5g specification, and both the 0.3g and 0.5g paracetamol tablets have been approved by the NMPA for generic drug quality and therapeutic efficacy consistency evaluation.
Paracetamol tablets are mainly used for fever caused by common cold or influenza, and also used to relieve mild to moderate pain.
Related Articles
.png)
HKEX (00388) released its performance for the first three quarters of the year, with a net profit attributable to shareholders of 13.419 billion yuan, a year-on-year increase of 45%. Both income and profit reached record highs.

Huatai (06886): "24 Huatai S3" will redeem and delist on November 13th.

Huatai (06886): "20 Huatai C1" will be redeemed and delisted on November 13th.
HKEX (00388) released its performance for the first three quarters of the year, with a net profit attributable to shareholders of 13.419 billion yuan, a year-on-year increase of 45%. Both income and profit reached record highs.
.png)
Huatai (06886): "24 Huatai S3" will redeem and delist on November 13th.

Huatai (06886): "20 Huatai C1" will be redeemed and delisted on November 13th.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


